GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026

ConferenceNHS-GalleriPATHFINDER 2Positive

AI Analysis

Summary

GRAIL announced it will present data from NHS-Galleri and PATHFINDER 2 trials at two major oncology conferences in 2026, including six abstracts at EDCC covering clinical performance and health equity, and two abstracts at ESMO Congress.

Importance:5/10

Sentiment:

0.30

multi-cancer early detectionconference presentationhealth equityreal-world implementationEDCCESMO Congress 2026

Related Companies

$DFPH $MDCE $HIT $WHEN

Read the original article

Published by PR Newswire Clinical Trials on October 5, 2026 8:01 PM

Read Original